Literature DB >> 21934532

The contribution of depression to mortality among elderly with self-reported hypertension: analysis using a national representative longitudinal survey.

Pei-Lun Kuo1, Christy Pu.   

Abstract

OBJECTIVE: Previous research has suggested that hypertension and depression are two of the important causes of mortality among the elderly. This study aims to test the contribution of depression to mortality among elderly with self-reported hypertension.
METHODS: This research used data from the Survey of Health and Living Status of the Middle Age and Elderly (SHLS) conducted by the Bureau of Health Promotion, Department of Health in Taiwan. The 1989, 1996, 1999, 2003, and 2007 waves were used. In total, 3736 respondents aged 60 or above were analyzed. Participants were grouped by status of hypertension and depression. The contribution of depression to mortality among elderly with self-reported hypertension was estimated using Cox proportional hazard model. Analyses were separated into younger elderly individuals (<70 years) and older elderly individuals (≥ 70 years).
RESULTS: In the full model, the hazard ratios for mortality for the groups of not hypertensive/depressed, hypertensive/not depressed, and hypertensive/depressed were 1.12 [95% confidence interval (CI) 0.98-1.28], 1.32 (95% CI 1.19-1.46), and 1.54 (95% CI 1.29-1.83), respectively, compared with the reference group of not hypertensive/not depressed. The pattern remained the similar after separating the participants into the two age groups. However, much higher hazard ratios were observed for the older cohort.
CONCLUSION: Depression contributes significantly to the hypertension-mortality relationship for the elderly. For the elderly, hypertension should be tackled along with depression in order to reduce the mortality associated with hypertension.

Entities:  

Mesh:

Year:  2011        PMID: 21934532     DOI: 10.1097/HJH.0b013e32834b59ad

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  7 in total

1.  Depression in hypertension and blood pressure variability over shorter time periods.

Authors:  Tomoyuki Kabutoya; Kazuomi Kario
Journal:  Hypertens Res       Date:  2015-08-20       Impact factor: 3.872

Review 2.  [Antihypertensive therapy in the elderly].

Authors:  J Schrader; B Schrader
Journal:  Herz       Date:  2018-05       Impact factor: 1.443

3.  Angiotensin-I Converting Enzyme (ACE) Inhibitory and Anti-Oxidant Activities of Sea Cucumber (Actinopyga lecanora) Hydrolysates.

Authors:  Raheleh Ghanbari; Mohammad Zarei; Afshin Ebrahimpour; Azizah Abdul-Hamid; Amin Ismail; Nazamid Saari
Journal:  Int J Mol Sci       Date:  2015-12-04       Impact factor: 5.923

4.  Impact of major depression on cardiovascular outcomes for individuals with hypertension: prospective survival analysis in UK Biobank.

Authors:  Nicholas Graham; Joey Ward; Daniel Mackay; J P Pell; Jonathan Cavanagh; Sandosh Padmanabhan; Daniel J Smith
Journal:  BMJ Open       Date:  2019-09-30       Impact factor: 2.692

Review 5.  Mental health problems and hypertension in the elderly: Review from the HOPE Asia Network.

Authors:  Yuda Turana; Jeslyn Tengkawan; Yook C Chia; Jinho Shin; Chen-Huan Chen; Sungha Park; Kelvin Tsoi; Peera Buranakitjaroen; Arieska A Soenarta; Saulat Siddique; Hao-Min Cheng; Jam C Tay; Boon W Teo; Tzung-Dau Wang; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-12-07       Impact factor: 3.738

6.  Association between physical activity dimensions and the risk of hypertension among middle and older adults: A cross-sectional study in China.

Authors:  Linlin Zhou; Wei Feng; Na Xiang; Yue Cheng; Xudong Ya; Mingxia Wang; Xingqi Wang; Yujia Liu
Journal:  Front Public Health       Date:  2022-09-24

7.  The older the better: are elderly study participants more non-representative? A cross-sectional analysis of clinical trial and observational study samples.

Authors:  Beatrice A Golomb; Virginia T Chan; Marcella A Evans; Sabrina Koperski; Halbert L White; Michael H Criqui
Journal:  BMJ Open       Date:  2012-12-14       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.